UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

Journal of viral hepatitis, 2006-01, Vol.13 (1), p.34-41

2006

Volltextzugriff (PDF)

Estimates on HCV disease burden worldwide - filling the gaps

Journal of viral hepatitis, 2015-01, Vol.22 (s1), p.1-5

2015

Volltextzugriff (PDF)

Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward)

Journal of viral hepatitis, 2014-05, Vol.21 (s1), p.1-4

2014

Volltextzugriff (PDF)

Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience

Drug and alcohol dependence, 2020-01, Vol.206, p.107705-107705, Article 107705

2020

Volltextzugriff (PDF)

Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden

Journal of viral hepatitis, 2009-07, Vol.16 (7), p.453-463

2009

Volltextzugriff (PDF)

Patterns and Characteristics of Hepatitis C Transmission Clusters among HIV-Positive and HIV-Negative Individuals in the Australian Trial in Acute Hepatitis C

Clinical infectious diseases, 2011-03, Vol.52 (6), p.803-811

2011

Volltextzugriff (PDF)

Characteristics and Treatment Outcomes among HIV-Infected Individuals in the Australian Trial in Acute Hepatitis C

Clinical infectious diseases, 2009-03, Vol.48 (5), p.650-658

2009

Volltextzugriff (PDF)

Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel

The International journal of drug policy, 2021-12, Vol.98, p.103379-103379, Article 103379

2021

Volltextzugriff (PDF)

Hepatitis C Virus Therapeutic Development: In Pursuit of "Perfectovir"

Clinical infectious diseases, 2015-06, Vol.60 (12), p.1829-1836

2015

Volltextzugriff (PDF)

Estimating HCV disease burden—volume 4 (editorial)

Journal of viral hepatitis, 2017-11, Vol.24 (S2), p.4-7

2017

Volltextzugriff (PDF)

Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study

The International journal of drug policy, 2015-10, Vol.26 (10), p.984-991

2015

Volltextzugriff (PDF)

Uptake of direct‐acting antiviral treatment for chronic hepatitis C in Australia

Journal of viral hepatitis, 2018-06, Vol.25 (6), p.640-648

2018

Volltextzugriff (PDF)

Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study

Drug and alcohol dependence, 2010-03, Vol.107 (2), p.244-249

2010

Volltextzugriff (PDF)

High incidence of hepatitis C virus reinfection within a cohort of injecting drug users

Journal of viral hepatitis, 2007-06, Vol.14 (6), p.413-418

2007

Volltextzugriff (PDF)

The impact of injecting drug use status on hepatitis C-related referral and treatment

Drug and alcohol dependence, 2005-01, Vol.77 (1), p.81-86

2005

Volltextzugriff (PDF)

Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study

BMJ, 1998-08, Vol.317 (7156), p.433-437

International edition, 1998

Volltextzugriff (PDF)

Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study

The International journal of drug policy, 2021-10, Vol.96, p.103421-103421, Article 103421

2021

Volltextzugriff (PDF)

A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs

Journal of epidemiology and community health (1979), 2015-08, Vol.69 (8), p.745-752

2015

Volltextzugriff (PDF)

HCV reinfection incidence among individuals treated for recent infection

Journal of viral hepatitis, 2017-05, Vol.24 (5), p.359-370

2017

Volltextzugriff (PDF)

Changes to AIDS dementia complex in the era of highly active antiretroviral therapy

AIDS (London), 1999-07, Vol.13 (10), p.1249-1253

1999

Volltextzugriff (PDF)

Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study

Journal of viral hepatitis, 2014-08, Vol.21 (8), p.560-567

2014

Volltextzugriff (PDF)

Predicting progression to cirrhosis in chronic hepatitis C virus infection

Journal of viral hepatitis, 2003-07, Vol.10 (4), p.285-293

2003

Volltextzugriff (PDF)

Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005‐2014: The HITS‐p study

Journal of viral hepatitis, 2017-09, Vol.24 (9), p.733-741

2017

Volltextzugriff (PDF)

“You need a designated officer” – Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting

The International journal of drug policy, 2022-08, Vol.106, p.103746-103746, Article 103746

2022

Volltextzugriff (PDF)

Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users

Epidemiology and infection, 2007-01, Vol.135 (1), p.144-150

2007

Volltextzugriff (PDF)

1 – 25 von 1.614

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.365)
Mit Volltextzugriff
(1.294)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

Estimates on HCV disease burden worldwide - filling the gaps

Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward)

Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience

Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden

Patterns and Characteristics of Hepatitis C Transmission Clusters among HIV-Positive and HIV-Negative Individuals in the Australian Trial in Acute Hepatitis C

Characteristics and Treatment Outcomes among HIV-Infected Individuals in the Australian Trial in Acute Hepatitis C

Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel

Hepatitis C Virus Therapeutic Development: In Pursuit of "Perfectovir"

Estimating HCV disease burden—volume 4 (editorial)

Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study

Uptake of direct‐acting antiviral treatment for chronic hepatitis C in Australia

Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study

High incidence of hepatitis C virus reinfection within a cohort of injecting drug users

The impact of injecting drug use status on hepatitis C-related referral and treatment

Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study

Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study

A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs

HCV reinfection incidence among individuals treated for recent infection

Changes to AIDS dementia complex in the era of highly active antiretroviral therapy

Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study

Predicting progression to cirrhosis in chronic hepatitis C virus infection

Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005‐2014: The HITS‐p study

“You need a designated officer” – Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting

Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users

Suchergebnisse filtern